Protagonist Therapeutics (PTGX) Amortizatization of Intangibles (2016 - 2026)

Protagonist Therapeutics has disclosed Amortizatization of Intangibles across 11 years of filings, most recently posting $1.0 million for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $1.0 million, down 55.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (down 37.6% YoY), and the FY2025 annual result was $7.2 million, down 18.61% from the prior year.
• Amortizatization of Intangibles came in at $1.0 million for Q1 2026 at Protagonist Therapeutics, down from $1.3 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $2.8 million in Q3 2024 to a low of -$1.2 million in Q4 2022.
• The 5-year median for Amortizatization of Intangibles is $1.3 million (2025), against an average of $1.3 million.
• Across the five-year window, Amortizatization of Intangibles slumped 136.61% in 2022 and surged 2010.34% in 2024, its largest moves.
• Protagonist Therapeutics' Amortizatization of Intangibles stood at -$1.2 million in 2022, then surged by 334.44% to $2.8 million in 2023, then dropped by 2.06% to $2.8 million in 2024, then slumped by 51.59% to $1.3 million in 2025, then declined by 23.28% to $1.0 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $1.0 million (Q1 2026), $1.3 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.